-
公开(公告)号:TR9801102T2
公开(公告)日:1998-12-21
申请号:TR9801102
申请日:1996-12-11
Applicant: BASF AG
Inventor: AMBERG WILHELM , BARLOZZARI TERESA , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , HEGE HANS-GUENTHER , JANSSEN BERND , KLING ANDREAS , LIETZ HELMUT , RITTER KURT , ULLRICH MARTINA , WEYMANN JURGEN , ZIERKE THOMAS
CPC classification number: A61K38/08
-
公开(公告)号:TR199801102T2
公开(公告)日:1998-12-21
申请号:TR9801102
申请日:1996-12-11
Applicant: BASF AG
Inventor: AMBERG WILHELM , BARLOZZARI TERESA , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , HEGE HANS-GUENTHER , JANSSEN BERND , KLING ANDREAS , LIETZ HELMUT , RITTER KURT , ULLRICH MARTINA , WEYMANN JURGEN , ZIERKE THOMAS
Abstract: Novel peptides of the formula R R N-CHX-CO-A-B-D-E-(G)s-K in which R , R , A, B, D, E, G, K, X, and s have the meanings stated in the description, and the preparation thereof are described. The novel peptides have an antineoplastic effect.
-
公开(公告)号:ZA973098B
公开(公告)日:1998-10-12
申请号:ZA973098
申请日:1997-04-11
Applicant: BASF AG
Inventor: RIECHERS HARTMUT , KLINGE DAGMAR , AMBERG WILHELM , KLING ANDREAS , HILLEN HEINZ , UNGER LILIANE , ELGER BERND
IPC: C07D251/30 , A61K31/00 , A61K31/505 , A61K31/517 , A61K31/529 , A61K31/53 , A61P7/00 , A61P9/00 , A61P9/02 , A61P9/12 , A61P13/00 , A61P13/08 , A61P13/12 , C07D239/34 , C07D239/46 , C07D239/52 , C07D239/60 , C07D239/70 , C07D251/48 , C07D403/12 , C07D491/044 , C07D , A61K
Abstract: The invention relates to carboxylic acid derivatives of the formulawhere the radicals have the meanings defined in the description, to the preparation of these compounds and to their use as drugs.
-
公开(公告)号:ZA973096B
公开(公告)日:1998-10-12
申请号:ZA973096
申请日:1997-04-11
Applicant: BASF AG
Inventor: AMBERG WILHELM , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , BAUMANN ERNST , UNGER LILIANE , RASCHACK MANFRED , HERGENROEDER STEFAN , SCHULT SABINE
IPC: A61K31/00 , A61K31/47 , A61K31/505 , A61P9/00 , A61P9/12 , A61P13/00 , A61P13/12 , C07D215/22 , C07D215/227 , C07D239/34 , C07D239/60 , C07D401/12 , C07D403/12 , C07D , A61K
Abstract: PCT No. PCT/EP97/01687 Sec. 371 Date Oct. 8, 1998 Sec. 102(e) Date Oct. 8, 1998 PCT Filed Apr. 4, 1997 PCT Pub. No. WO97/38982 PCT Pub. Date Oct. 23, 1997Carboxylic acid derivatives of the formula I where the radicals have the meanings stated in the description, and the preparation of these agreements [sic] and their use as drugs are described.
-
公开(公告)号:ZA9703097B
公开(公告)日:1998-10-12
申请号:ZA9703097
申请日:1997-04-11
Applicant: BASF AG
Inventor: KLINGE DAGMAR , AMBERG WILHELM , BAUMANN ERNST , KLING ANDREAS , RIECHERS HARTMUT , UNGER LILIANE , RASCHACK MANFRED , HERGENROEDER STEFAN , SCHULT SABINE
IPC: A61K31/00 , A61K31/505 , A61K31/517 , A61P5/42 , A61P9/10 , A61P13/00 , A61P13/12 , C07D217/22 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/56 , C07D239/60 , C07D239/70 , C07D239/80 , C07D239/96 , C07D251/20 , C07D251/22 , C07D251/30 , C07D251/38 , C07D251/52 , C07D403/12 , C07D405/12 , C07D471/04 , C07D487/04 , C07D491/04 , C07D491/044 , C07D , A61K
CPC classification number: C07D217/22 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/56 , C07D239/60 , C07D239/80 , C07D239/96 , C07D251/20 , C07D251/22 , C07D251/30 , C07D251/38 , C07D251/52 , C07D471/04 , C07D487/04 , C07D491/04
-
公开(公告)号:MX9803662A
公开(公告)日:1998-09-30
申请号:MX9803662
申请日:1998-05-08
Applicant: BASF AG
Inventor: KLING ANDREAS , JANSSEN BERND , AMBERG WILHELM , HAUPT ANDREAS , RITTER KURT , BUSCHMANN ERNST , BERNARD HARALD , MULLER STEFAN , ZIERKE THOMAS
Abstract: La presente invencion se refiere a los péptidos novedosos de la formula: A-B-D-E-F-L, en donde A, B, D, E, F y L tienen los significados mencionados en la especificacion, y su preparacion. Los compuestos novedosos son adecuados para controlar enfermedades.
-
167.
公开(公告)号:AU6448298A
公开(公告)日:1998-09-29
申请号:AU6448298
申请日:1998-03-05
Applicant: BASF AG , BASF BIORESEARCH CORP
Inventor: RITTER KURT , AMBERG WILHELM , BARLOZZARI TERESA , HAUPT ANDREAS , JANSSEN BERND , KLING ANDREAS
Abstract: The present invention relates to novel peptides useful as anti-cancer agents. The compounds of the invention are of Formula I,A-B-D-E-F-G(I)A, B, D, and E are alpha -amino acid residues. In one embodiment, F is an azacycloalkanecarboxylic acid residue. In this embodiment, G is a monovalent radical, for example, a hydrogen atom, an alkyl group, an aryl group, or a heteroaryl group. In another embodiment, F is an azacycloalkyl group and G is a heteroaryl group connected to F by a carbon-carbon bond. In another embodiment, the invention includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
-
公开(公告)号:CZ9801391A3
公开(公告)日:1998-09-16
申请号:CZ139198
申请日:1996-10-30
Applicant: BASF AG
Inventor: KLING ANDREAS , JANSSEN BERND , AMBERG WILHELM , HAUPT ANDREAS , RITTER KURT , BUSCHMANN ERNST , BERNARD HARALD , MULLER STEFAN , ZIERKE THOMAS , BARLOZZARI TERESA , DE ARRUDA MONIKA , ROBINSON SIMON
-
169.
公开(公告)号:CA2275256A1
公开(公告)日:1998-06-25
申请号:CA2275256
申请日:1997-12-04
Applicant: BASF AG
Inventor: UNGER LILIANE , RASCHACK MANFRED , KLING ANDREAS , HERGENROEDER STEFAN , RIECHERS HARTMUT , KLINGE DAGMAR , JANSEN ROLF , AMBERG WILHELM
IPC: C07D253/06 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/53 , A61P9/10 , A61P9/12 , A61P11/06 , A61P13/08 , C07D237/14 , C07D237/16 , C07D241/18 , C07D253/07 , C07D253/075 , C07D253/10 , C07D403/12 , C07D491/04 , C07D253/08 , C07D237/18 , C07D237/20 , C07D241/20 , C07D237/22
Abstract: The present invention relates to carboxylic acid derivatives of formula (I), wherein the substituents have the meaning cited in the description, as well as to the production and use of said substances as endothelin receptor antagonists.
-
公开(公告)号:ZA9610510B
公开(公告)日:1998-06-15
申请号:ZA9610510
申请日:1996-12-13
Applicant: BASF AG
Inventor: AMBERG WILHELM , BARLOZZARI TERESA , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , HEGE HANS-GUENTER , JANSSEN BERND , KLING ANDREAS , LIETZ HELMUT , RITTER KURT , ULLRICH MARTINA , WEYMANN JUERGEN , ZIERKE THOMAS
Abstract: Novel peptides of the formula R R N-CHX-CO-A-B-D-E-(G)s-K in which R , R , A, B, D, E, G, K, X, and s have the meanings stated in the description, and the preparation thereof are described. The novel peptides have an antineoplastic effect.
-
-
-
-
-
-
-
-
-